← Leaderboards
Christine J Moe
University Of North Carolina Chapel Hill
$3,825,642
Attributed
$3,825,642
Total exposure
5
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$3,825,642 · 5
By mechanism
M01$3,825,642 · 5
Top collaborators
No co-investigators on record.
Most similar at University Of North Carolina Chapel Hill
Same institution · by research overlap
- Douglas A Drossman$8,090,089
- Ralph S Baric$89,182,261
- Melanie S Joy$4,717,709
- Scott H Donaldson$8,054,486
- Robert E. Johnston$11,943,669
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman SubjectGastroenteritisRna VirusVolunteerEpidemiologyDosageGastrointestinal InfectionHuman Therapy EvaluationIntravenous AdministrationVirus Infection MechanismOndansetronGastrointestinal Disorder ChemotherapyParasitic Gastrointestinal DisorderProtozoal InfectionPurposeResearch PersonnelResourcesSourceSurfaceUnited States National Institutes Of HealthVolunteers, HumanWaterCalicivirus
Grant awards (23)
ASSESSMENT OF CALICIVIRUS SURVIVAL IN SURFACE WATER AND SUBSURFACE WATER$29,683
M01 · FY2007 · RR · contact PI
DETERMINATION OF THE INFECTIOUS DOSE OF NORWALK VIRUS IN HUMAN VOLUNTEERS$190,747
M01 · FY2002 · RR
INFECTIVITY OF NORWALK &NORWALK LIKE VIRUSES$190,747
M01 · FY2002 · RR
STUDY OF INTRAVENOUS ONDANSETRON FOR CONTROL OF GASTROENTERITIS$190,747
M01 · FY2002 · RR
STUDY OF INTRAVENOUS ONDANSETRON FOR CONTROL OF GASTROENTERITIS$294,555
M01 · FY2001 · RR
INFECTIVITY OF NORWALK &NORWALK LIKE VIRUSES$294,555
M01 · FY2001 · RR
DETERMINATION OF THE INFECTIOUS DOSE OF NORWALK VIRUS IN HUMAN VOLUNTEERS$294,555
M01 · FY2001 · RR
INFECTIVITY OF NORWALK &NORWALK LIKE VIRUSES$190,747
M01 · FY2001 · RR
DETERMINATION OF THE INFECTIOUS DOSE OF NORWALK VIRUS IN HUMAN VOLUNTEERS$190,747
M01 · FY2001 · RR
STUDY OF INTRAVENOUS ONDANSETRON FOR CONTROL OF GASTROENTERITIS$190,747
M01 · FY2001 · RR
DETERMINATION OF THE INFECTIOUS DOSE OF NORWALK VIRUS IN HUMAN VOLUNTEERS$294,555
M01 · FY2000 · RR
DETERMINATION OF THE INFECTIOUS DOSE OF NORWALK VIRUS IN HUMAN VOLUNTEERS$294,555
M01 · FY2000 · RR
DETERMINATION OF THE INFECTIOUS DOSE OF NORWALK VIRUS IN HUMAN VOLUNTEERS$294,555
M01 · FY2000 · RR
STUDY OF INTRAVENOUS ONDANSETRON FOR CONTROL OF GASTROENTERITIS$294,555
M01 · FY2000 · RR
STUDY OF INTRAVENOUS ONDANSETRON FOR CONTROL OF GASTROENTERITIS$294,555
M01 · FY2000 · RR
STUDY OF INTRAVENOUS ONDANSETRON FOR CONTROL OF GASTROENTERITIS$294,555
M01 · FY2000 · RR
STUDY OF INTRAVENOUS ONDANSETRON FOR CONTROL OF GASTROENTERITIS$241
M01 · FY2000 · RR
DETERMINATION OF THE INFECTIOUS DOSE OF NORWALK VIRUS IN HUMAN VOLUNTEERS$241
M01 · FY2000 · RR
INFECTIVITY OF NORWALK &NORWALK LIKE VIRUSES$0
M01 · FY2000 · RR
INFECTIVITY OF CYCLOSPORA CAYETANESIS IN HUMAN VOLUNTEERS$0
M01 · FY2000 · RR
INFECTIVITY OF NORWALK &NORWALK LIKE VIRUSES$0
M01 · FY2000 · RR
INFECTIVITY OF NORWALK &NORWALK LIKE VIRUSES$0
M01 · FY2000 · RR
INFECTIVITY OF NORWALK &NORWALK LIKE VIRUSES$0
M01 · FY2000 · RR